Transcatheter Aortic Valve Replacement Market to Gain Impetus in Response to Rising Awareness About Minimally Invasive Surgeries
Transcatherer aortic valve replacement (TAVR) is touted by experts as a radical innovation in the field of cardiovascular surgery and interventional cardiology. While surgical aortic valve replacement continues to be a standard procedure, it is considered unsuitable for almost 30% of the patients either because of their advanced age or due to multiple comorbidities. TAVR however offers less invasive treatment options and also promises better outcome. This is identified as a chief driver of the global transcatheter aortic valve replacement...
View full press release